Replies to post #225540 on Innovation Pharmaceuticals Inc (IPIX)

[sox040713]

Interesting find. It tells me most patients aren’t satisfied with current treatments. Their feedback might change how the FDA review NDA for psoriasis drugs.

For example, if patients complain itching is impacting their quality of life, the FDA might approve drugs that can reduce itching, even if efficacy isn’t as good as the approved drugs.